drugset

drugset / Trial / NCT00241098

The VALIDATE Study of Valsartan for Patients With Early Stage Heart Failure

NCT00241098 ↗

Phase 4 Completed 37 enrolled Novartis

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study to evaluate the response of patients with hypertension and early stage heart failure to valsartan.

Timeline

Start: 2003-05
Primary completion: 2005-06
Completion: 2005-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Valsartan	Small molecule	—	—

Indications